Ignite Creation Date:
2024-05-06 @ 5:46 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05429697
Status:
RECRUITING
Last Update Posted:
2022-09-27
First Post:
2022-06-17
Brief Title:
Study of SMT-NK Inj Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer
Sponsor:
SMT bio Co Ltd
Organization:
SMT bio Co Ltd
Organization Data
Organization:
SMT bio Co Ltd
Class:
INDUSTRY
Study ID:
SNK-SIT-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SMT bio Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None